Biogen | BIIB - Modal Dan Cadangan





Modal Dan Cadangan Perubahan Tanggal
AbbVie USD -5.94B 721M 2026-06
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
ALKERMES USD 1.81B 57.02M 2026-06
Amgen USD 9.19B 532M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Biogen USD 18.85B 196.3M 2026-06
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Eli Lilly USD 31.2B 4.66B 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Incyte USD 6.34B 721.58M 2026-06
Merck USD 45.88B 6.73B 2026-03
Moderna USD 6.76B 647M 2026-06
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 69.57B 3.24B 2026-06
Sanofi EUR 73.14B 1.43B 2026-03
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
United Therapeutics USD 5.9B 1.2B 2026-03
Vertex Pharmaceuticals USD 20.25B 886M 2026-06